Companies that prefer to conduct in-house safety/efficacy assessments can still make use of TNO’s expertise. Our intuitive, web-based TargetTri platform efficiently extracts essential, target-centric information from multiple data sources, including PubMed. Unlike other commercial data collection services or manual searches, TargetTri is enhanced with TNO’s deep understanding of disease mechanisms and our work on hundreds of TSAs and TEAs. We support AI-based searches with our own enriched terminology, allowing for optimal searching. The proprietary system also contains expert-based ontologies and guides data interpretation by weighing data relevance. This saves significant time and resources, as compared to manual searches.